Table 1.
Cost effective analysis of vaccinating a single cohort of 12 year old girls with HPV 16/18 vaccine for 5 East African Countries
|
Country |
Reduction in lifetime risk of cervical cancer (%) |
Cancer Incidence (ASR) |
ICER (I$ DALY averted) |
ICER (I$ DALY averted) |
ICER (I$ DALY averted) |
ICER (I$ DALY averted) |
|---|---|---|---|---|---|---|
| [I$ 10 per vaccinated girl] | [I$ 25 per vaccinated girl] | [I$ 50 per vaccinated girl] | ||||
| Burundi |
55.4 |
42.7 |
7,283 |
70 |
220 |
480 |
| Kenya |
55.4 |
28.7 |
18,047 |
60 |
320 |
770 |
| Rwanda |
55.4 |
49.4 |
8,786 |
c |
130 |
370 |
| Tanzania |
50.7 |
68.6 |
50,110 |
50 |
160 |
340 |
| Uganda | 53.7 | 36.3 | 33,813 | c | 100 | 340 |
Source: Adopted from [41].
c Strategy cost effective compared to no vaccination.
ASR: Age standardized incidence rate.
DALYs: Disability Adjusted Life Years.
ICER: Incremental cost-effectiveness ratios.
I$: International Dollar.